Key result
Non-alcoholic fatty liver disease was evaluated against the general population across 4 European primary care databases for incident acute myocardial infarction and stroke.
Answers are grounded in this paper and cite their sources.
This editorial discusses the ongoing debate regarding the independent contribution of non-alcoholic fatty liver disease (NAFLD) to incident cardiovascular disease events in light of a recent European primary care database study.
Cardiovascular disease (CVD) is the leading cause of death among individuals with non-alcoholic fatty liver disease (NAFLD), and a growing body of evidence indicates that NAFLD is strongly associated with an increased risk of incident CVD events. The independent contribution of NAFLD to CVD, however, remains an area of debate. Recently, Alexander et al. performed a population-based, retrospective, case-control study using data from four large European electronic primary care databases (United Kingdom, Netherlands, Italy and Spain) to estimate the incidence of fatal and non-fatal acute myocardial infarction (AMI) and ischemic/unspecified stroke in patients with NAFLD compared to the general population after adjustment for traditional CVD risk factors.
No takes yet. Share an insight, caveat, or question.
Roden et al. (2020) conducted an editorial in Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic fatty liver disease (NAFLD) vs. General population without NAFLD was evaluated on Incidence of fatal and non-fatal acute myocardial infarction (AMI) and ischemic/unspecified stroke. Non-alcoholic fatty liver disease was evaluated against the general population across 4 European primary care databases for incident acute myocardial infarction and stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: